The Room Where it Happened: Menopause, UTIs, and What’s Changed Webinar

[madman]

A major shift just happened in menopause care.

With the FDA removing outdated boxed warnings on hormone therapy—first announced in November 2025 and finalized in February 2026—we’re entering a new era. But what’s actually changed, and what does it mean for patients and clinicians?

Join Dr. Rubin as she talks about the huge progress made in Menopause and UTI treatment in the last 6 months.




She'll talk about the labeling changes for all hormone therapy, and the new impactful collaborations and public awareness efforts supporting vaginal estrogen for UTI prevention — and why it matters for both patients and clinicians.


In this session, she’ll cover:

• What the FDA actually changed (and why it’s a big deal)
• What we’ve been getting wrong about hormone therapy
• What this means for prescribing — and for patients trying to access care
• How to talk about hormones with clarity and confidence
• What’s next in the movement to improve menopause care

 

[madman]

Thread 'FDA Expert Panel on Menopause and HRT Recommends Removing Black Box Labels'

Jul 17, 2025

This was a very important meeting with top experts that are trying to change guidelines. This FDA panel recently recommended removing the warning (“black box”) labels on menopausal HRT, citing potential benefits like reduced heart attack and bone fracture risk—and arguing the warning discourages appropriate use.

FDA Expert Panel on Menopause and Hormone Replacement Therapy for Women​

Hopefully, we will see progress in this field after the confusing and sometimes misleading conclusions of the WHI (“Women’s Health Initiative”), a large National Institutes of Health trial...

• madman
• menopause; hrt; estrogen; testosterone; health
• Replies: 17
• Forum: HRT in Women